Copyright © 2000 by the European Society of Cardiology.
Editorial
Heart failure: we need more trials in typical patients
Clinical Research Initiative in Heart Failure, University of Glasgow, Glasgow, Scotland, U.K.
References
- Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355
[Abstract/Free Full Text] - Lancet. 1999;353:9–13[CrossRef][Web of Science][Medline]
- Lancet. 1999;353:2001–2007[CrossRef][Web of Science][Medline]
- Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–717
[Abstract/Free Full Text] - N Engl J Med. 1987;316:1429–1435[Abstract]
- N Engl J Med. 1991;325:293–302[Abstract]
- N Engl J Med. 1997;336:525–533
[Abstract/Free Full Text] - Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. Eur Heart J. 2000;21:763–769
[Abstract/Free Full Text] - McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980–1990. Eur Heart J. 1993;14:1158–1162
[Abstract/Free Full Text] - Reitsma JB, Mosterd A, De Craen AJ. Increase in hospital admission rates for heart failure in The Netherlands, 1980–1993. Heart. 1996;76:388–392
[Abstract/Free Full Text] - Rodriguez-Artalejo F, Guallar-Castillon P, Banegas Banegas JR, del Rey Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980–1993. Eur Heart J. 1997;18:1771–1779
[Abstract/Free Full Text] - Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJ. Failure of women's hearts. Circulation. 1999;99:2334–2341
[Free Full Text] - Pitt B, Segal R, Martinez FA. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747–752[CrossRef][Web of Science][Medline]
- Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, Olofsson B, Ostergren J, Yusuf S. Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm— Programme Investigators. J Card Fail. 1999;5:276–282[CrossRef][Medline]
- Cleland JGF, Tendera M, Adamus J. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. Eur J Heart Failure. 1999;1:211–217[CrossRef][Web of Science][Medline]
- Torp-Pedersen C. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999;341:857–865
[Abstract/Free Full Text] - Eur J Heart Failure. 1999;1:139–144
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Gheorghiade and F. Zannad Modern management of acute heart failure syndromes Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B3 - B7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade and G. Filippatos Reassessing treatment of acute heart failure syndromes: the ADHERE Registry Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B13 - B19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. McMurray Making sense of SENIORS Eur. Heart J., February 1, 2005; 26(3): 203 - 206. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sumukadas, M. D Witham, A. D Struthers, and M. E. McMurdo Are elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors? Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 26 - 26. [PDF]
|
|
|
|
 |
|
 M. Martinez-Selles, J. A. G. Robles, R. Munoz, J. A. Serrano, E. Frades, M. D. Munoa, and J. Almendral Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations Eur J Heart Fail, March 1, 2004; 6(2): 219 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Martinez-Selles, J. A.G. Robles, L. Prieto, M. D. Munoa, E. Frades, O. Diaz-Castro, and J. Almendral Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure Eur. Heart J., November 2, 2003; 24(22): 2046 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D B McKenzie and A J Cowley Drug therapy in chronic heart failure Postgrad. Med. J., November 1, 2003; 79(937): 634 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McMurray, J. Ostergren, M. Pfeffer, K. Swedberg, C. Granger, S. Yusuf, P. Held, E. Michelson, B. Olofsson, and On behalf of the CHARM committees and investigator Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme Eur J Heart Fail, June 1, 2003; 5(3): 261 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Martinez-Selles, J. A. G. Robles, L. Prieto, J. A. Serrano, R. Munoz, E. Frades, and J. Almendral Annual rates of admission and seasonal variations in hospitalizations for heart failure Eur J Heart Fail, December 1, 2002; 4(6): 779 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S D Hutcheon, N D Gillespie, I K Crombie, A D Struthers, and M E T McMurdo Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial Heart, October 1, 2002; 88(4): 373 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.J.V McMurray and S Stewart The burden of heart failure Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D50 - D58. [Abstract] [PDF]
|
|
|
|
|
|
S. L. Rywik, H. Wagrowska, G. Broda, A. Sarnecka, A. Pytlak, M. Polakowska, J. Drewla, and J. Korewicki Heart failure in patients seeking medical help at outpatients clinics. Part I. General characteristics Eur J Heart Fail, December 1, 2000; 2(4): 413 - 421. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||